F indings from a Phase I trial initiated by Dana-Farber Cancer Institute have demonstrated that the NeoVax personalised cancer vaccine’s updated formula and delivery, NeoVax MI ,is not only feasible ...

The risk of death from kidney cancer has decreased in the United States in recent years, but the risk varies by sex, race, and ethnicity, according to research published in The Oncologist.

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...

Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

The global cancer vaccine market is grow due to rising cancer prevalence, increasing adoption of immunotherapies, and advancements in vaccine development technologies.

RFK Jr. announced a halt to all U.S. funding for the global Gavi vaccine alliance. One expert calls it a "travesty and a nightmare." ...

A cancer specialist at Weston Park Cancer Centre has won a national award following a public vote for her outstanding contribution to UK cancer vaccine research.

Find out about possible causes of cancer, how cancer starts and grows, tests to diagnose it, and general information about treatments.

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.

Researchers at Queen’s University of Belfast and collaborators have developed a DNA vaccine against high-grade serous ovarian cancer. The vaccine encodes PRAME, which the researchers found to be ...